Crossref
Advances in the Efficacy of Novel Targeted Therapeutics for HR+/HER2- Breast Cancer
Pharmacy Information · 2026 · 15 (06) · 530-537
DOI: 10.12677/pi.2026.156056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy Information, 2026. Verfasst von 歆睿 张. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
张, 歆. (2026). Advances in the Efficacy of Novel Targeted Therapeutics for HR+/HER2- Breast Cancer. Pharmacy Information, 15(06), 530-537. https://doi.org/10.12677/pi.2026.156056
Vancouver
张 歆. Advances in the Efficacy of Novel Targeted Therapeutics for HR+/HER2- Breast Cancer. Pharmacy Information. 2026;15(06):530-537. doi:10.12677/pi.2026.156056
BibTeX
@article{2026,
author = {张, 歆睿},
title = {Advances in the Efficacy of Novel Targeted Therapeutics for HR+/HER2- Breast Cancer},
journal = {Pharmacy Information},
year = {2026},
volume = {15},
number = {06},
pages = {530--537},
doi = {10.12677/pi.2026.156056}
}
EUVIMED